These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11704863)

  • 1. Enhanced sensitivity to apoptosis in Ras-transformed thyroid cells.
    Cheng G; Meinkoth JL
    Oncogene; 2001 Nov; 20(50):7334-41. PubMed ID: 11704863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
    Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
    Ulkü AS; Schäfer R; Der CJ
    Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of myeloid cell growth by distinct effectors of Ras.
    Matsuguchi T; Kraft AS
    Oncogene; 1998 Nov; 17(21):2701-9. PubMed ID: 9840934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential sensitivity of normal and H-ras oncogene-transformed rat kidney epithelial cells to okadaic acid-induced apoptosis.
    Davis MA; Chang SH; Trump BF
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):93-101. PubMed ID: 8917680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
    Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
    Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K.
    Ramírez de Molina A; Penalva V; Lucas L; Lacal JC
    Oncogene; 2002 Jan; 21(6):937-46. PubMed ID: 11840339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cAMP, PKA and Rap1A in thyroid follicular cell survival.
    Saavedra AP; Tsygankova OM; Prendergast GV; Dworet JH; Cheng G; Meinkoth JL
    Oncogene; 2002 Jan; 21(5):778-88. PubMed ID: 11850806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI-3-kinase is an essential anti-apoptotic effector in the proliferative response of primary human epithelial cells to mutant RAS.
    Gire V; Marshall C; Wynford-Thomas D
    Oncogene; 2000 May; 19(19):2269-76. PubMed ID: 10822377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.
    Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD
    Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Ras transformation of human thyroid epithelial cells.
    Poghosyan Z; Wynford-Thomas D
    Methods Enzymol; 2006; 407():648-60. PubMed ID: 16757359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
    Xin H; Geng Y; Pramanik R; Choubey D
    J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
    Gallagher AP; Burnett AK; Bowen DT; Darley RL
    Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis.
    Jo H; Zhang R; Zhang H; McKinsey TA; Shao J; Beauchamp RD; Ballard DW; Liang P
    Oncogene; 2000 Feb; 19(7):841-9. PubMed ID: 10702792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras signaling through PI3K confers hormone-independent proliferation that is compatible with differentiation.
    Cass LA; Meinkoth JL
    Oncogene; 2000 Feb; 19(7):924-32. PubMed ID: 10702801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
    Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ
    Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor.
    Zhang KX; Ward KR; Schrader JW
    Mol Cancer Res; 2004 Apr; 2(4):242-55. PubMed ID: 15140946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
    Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
    Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.